Select Page


It’s time to demystify the technology behind Comfort Motion Global’s motion seat.

CMS’s proprietary software algorithm is an industry first, so it might not be clear to everyone why our solution is move scientifically and intuitively “good for you.” It goes beyond its low integration barrier of entry, the algorithm turns a single piece of software into a powerful, proactive solution to back fatigue.

Let’s talk a little bit more about the algorithm itself. First, we start with timing, The program can run for up to 36-minutes but is fully customizable within that timeframe. It is also smart, not only does the program start over automatically upon completion, it also pauses while the driver is braking. From there, we can move on the movements available from the program, you can program up to 12 lumbar support movements, 12 seat cushion and seat back movements, and 12 bolster movements.

The Algorithm


36 Minutes

12 Lumbar Support Movements

12 Seat Cushion and Seat Back Movements

12 Bolster Movements

Benefits of motion seat technology are unique, significant, and scientifically proven.

For more than a decade, we have been partnering with research universities to ensure that the CMG proprietary technology works. To date, we have worked with Rose-Hulman Institute of Technology, Logan University, and Ball State University.

Based on the tests that have been conducted to date, Comfort Motion Global’s motion algorithm:

  • Improves occupant comfort
  • Increases driver alertness
  • Pre-empts and reduces tissue fatigue
  • Reduces mental fatigue
  • Relieves pressure points
  • Improves circulation to the lower extremities
  • To learn about the specific results, please contact us today to set up a phone call or presentation.

University Tested, Scientifically Proven

Minimal effect on life of seat

Improved Alertness and Responsiveness

Reduced lower back muscle fatigue

Lew D Derrickson

Chief Executive Officer

Richard W. Ferguson

Chief Marketing Officer

Christopher Meyer

Chief Product Engineer

Dr. Paul Phipps

President/Director of Research and Development

Thomas K. Shine

Commercialization Officer